Effect of aging on the scotopic ERG and its daily rhythm. by Kenkichi Baba (322085)

“…<p>The amplitude of the a wave (A–C) and b wave (D–F) of the scotopic ERG steadily decreased during aging, and the daily rhythm in the a and b wave amplitude was only present in mice at 3 and 6 months (Two-way ANOVA, P<0.001, followed by Tukey tests). …”

Correlation between behavioural reactivity and brain responses. by Davide Bottari (343029)

“…(<b>c</b>) In both groups the mean amplitude of the pre-stimulus activity (leftmost dashed area in (<b>a</b>) see text) was unrelated to the RTs. …”

Cytoprotective gene regulation is essential to lifespan extension by diverse mechanisms. by David E. Shore (123998)

“…Lifespan was measured in three replicates comprising an average of 103 worms per condition. Data is presented as mean lifespan (columns 1–4), change mean lifespan in comparison to an empty vector RNAi control (column 5), or as the change in the extension of lifespan induced by each long-lived mutant (columns 6–8; for clarity, only decreases >15% are shown). …”

LP I_h metamodulation is rapid and reversible. by Wulf-Dieter C. Krenz (693267)

“…Data were plotted as the mean±SEM, n≥4 per time point. The data were best fitted with a double exponential equation yielding time constants of 24sec and 9.9min. …”

Inter-trial phase coherence and Phase Distributions. by Karla D. Ponjavic-Conte (289657)

“…There was a decrease of theta and alpha inter-trial phase coherence for Unattended Correct-rejections (but not Attended Hits) at approximately 300 to 400 ms post-stimulus in high-distraction. …”

Signal-to-noise ratio (SNR) of cortical neurons recorded from all animals across distinct survival times. by Marco Aurelio M. Freire (197478)

“…In latter survival time (6 months after the array implant), quality of recordings decreased as compared to previous time point, though a good SNR still had been identified (standard deviation threshold: SNR>std(SNR) = 1; and SNRn = 5 animals by time point); values expressed as mean ± SEM. …”

Course of cerebral extracellular glucose and lactate/pyruvate ratio in insulin-treated SAH patients developing DIND by Florian Schlenk (46916)

“…Data are expressed as mean ± standard error of daily medians calculated from hourly measured microdialysate levels of glucose and lactate:pyruvate (L/P) ratio in nine insulin-treated subarachnoid haemorrhage (SAH) patients developing delayed ischaemic neurological deficit (DIND). (*) indicates a trend (< 0.1) toward a decrease in cerebral glucose, comparing the levels at 2 days and 1 day before onset of DIND (Wilcoxon signed-rank test, = 0.068).…”

CS-US experiment. by Elías M. Fernández Santoro (22470299)

“…The CS pf sees a large decrease in weight. (B) Weight changes during plasticity, averages for each CS/US trial. …”

Characterization of glucose metabolism in imatinib-sensitive and -resistant cells. by Jérome Kluza (5649763)

“…Data are means +/− SD of three independent experiments (C) (left) Schematic overview of glucose metabolism to point out the position of studied genes in metabolism. …”

The changes in the sample sizes within each of the six participant sub-groups (using the stratification described in <i>Matching sub-groups outcome model</i> and adopted from [16])... by Ognjen Arandjelović (295373)

High Neto levels affect the BMP signaling. by Young-Jun Kim (696507)

Recent trends in white shark relative abundance. by Tobey H. Curtis (576240)

“…<p>Estimates of relative change in abundance (filled circles) with 95% credible intervals (dashed lines) for any reference year between 1990 and 2008 assuming no change in observation effort (black plot), a 25% and 50% increase in observation effort (green and red plots, respectively), and a 25% and 50% decrease in observation effort (blue and purple plots, respectively) for the original sightings time series from 1990 to 2009 (a) and the time series with sightings that occurred near Monomoy Island during that time frame removed (b).…”

Evolution of the short-term TEER in Calu-3 cell monolayers during the monolayer maturation. by Aizat Turdalieva (2512252)

Animals fed heat-killed HT115 have an impaired phenotype after anoxia treatment. by Bobby L. LaRue (231047)

“…<p>N2 adult hermaphrodites were fed either the OP50 or HT115 <i>E. coli</i> strain, raised at 25°C, transferred to heat-killed OP50 or HT115 and exposed to either three days (A) or four days of anoxia (B). …”

Median phyla frequencies under conditions of LSG and HSG. by J. Max Goodson (469397)

Determining tumor cell content in cultured malignant effusions. by Christian Ruiz (117039)

“…Example of the tumor cell decrease in a malignant effusion from a patient with lung adenocarcinoma. …”

SSVEP phase delay preceding un-cued gaze shifts. by Sarah Enos Watamura (283322)

“…The slight decrease in the average phase delay in the third shift set (0.490±0.013, 0.486±0.012, and 0.470±0.010 cycle in shift sets 1, 2, and 3, respectively; mean ± SEM), indicated by a main effect of Shift Set (<i>p</i> = .037), is evident. …”

SNP offset and number of mismatches. by Hans Binder (128524)

“…The homozygous-absent data (P-G'•G) were separately calculated for the three groups of mismatches, Aa, Ac and Ag: The respective curves are almost identical. Panel b: Relative decrease of the mean probe intensity as a function of #mm (symbols). …”

Proton Momentum Distribution and Diffusion Coefficient in Water: Two Sides of the Same Coin? by F. Bruni (1288989)

“…Water anomalous behavior in each of these regions manifests itself as a decrease of order or an increase of the diffusion coefficient upon increasing pressure and as a decrease of density upon cooling. …”

Data Sheet 1_Treatment with pemafibrate ameliorates fatty liver index and atherogenic lipid profiles in Japanese patients with type 2 diabetes mellitus.pdf by Toru Suzuki (512729)

“…There was no significant change in hemoglobin A1c level over time. FLI (mean ± standard deviation: 68.1 ± 21.9 vs. 39.6 ± 25.0, P < 0.001), but not FIB-4 index as a marker of hepatic fibrosis (median [interquartile range]: 1.04 [0.78-1.39] vs. 1.01 [0.68-1.36], P = 0.909), was significantly decreased by treatment with pemafibrate for 12M, and the proportion of patients with metabolic dysfunction-associated SLD (MASLD) was significantly decreased from 92.3% (baseline) to 61.5% (12M).…”